Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination-Reference-Cited by-全球学者库

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Published:2022-01-20 Issue:3 Volume:28 Page:486-489
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Cheng Samuel M. S.,Mok Chris Ka Pun^ORCID,Leung Yonna W. Y.,Ng Susanna S.,Chan Karl C. K.,Ko Fanny W.,Chen Chunke,Yiu Karen,Lam Bosco H. S.,Lau Eric H. Y.^ORCID,Chan Ken K. P.,Luk Leo L. H.,Li John K. C.,Tsang Leo C. H.,Poon Leo L. M.^ORCID,Hui David S. C.^ORCID,Peiris Malik^ORCID

Funder

Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund

National Natural Science Foundation of China

Research Grants Council, University Grants Committee

Food and Health Bureau

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-01704-7.pdf

Reference20 articles.

1. Viana, R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature (in the press). https://www.nature.com/articles/s41586-022-04411-y_reference.pdf

2. World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern 2021; https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

3. Addetia, A. et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate. J. Clin. Microbiol. 58, e02107-20 (2020).

4. McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature 590, 630–634 (2021).

5. Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205–1211 (2021).

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Immunological Memory: Unveiling Booster Doses to Bolster Vaccine Efficacy Against Evolving SARS-CoV-2 Mutant Variants;Current Microbiology;2024-02

2. High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1;Journal of Virology;2024-01-23

3. Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity;mBio;2024-01-09

4. Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy;Frontiers in Immunology;2024-01-08

5. Evaluation of antibody and T Cell immunity response in different immunization groups of inactive and mRNA COVID-19 vaccines;Diagnostic Microbiology and Infectious Disease;2024-01